Dr. David’s FDA Slide Presentation Regarding Pregnancy Safety Concerns with the Johnson & Johnson COVID-19 Vaccine
February 24, 2021
Dr. David Berger was invited to give an oral presentation at the FDA Vaccines and Related Biological Products Advisory Committee meeting (February 26, 2021) to discuss the Emergency Use Authorization (EUA) of the Johnson & Johsnon/Jansenn Biotech, Inc. COVID-19 Vaccine (Docket No. FDA-2021-N-0173). Dr. Berger will address continued COVID-19 vaccine hesitancy and safety concerns related to women of childbearing age. Below are the slides of Dr. Berger’s presentation to the committee.
DOWNLOAD DR. BERGER’S SLIDE PRESENTATION HERE:
Dr. David Berger (“Dr. David”), a Board Certified Pediatrician with over 20 years of experience as a clinician, has developed a national reputation in wholistic pediatric primary care. Dr. David is considered Tampa Bay area’s leading authority on medical cannabis for adults and children, and is one of the nation’s most experienced pediatricians using medical cannabis to help facilitate the treatment of children with chronic conditions.
Dr. David graduated from The Medical College of Pennsylvania in 1994 and completed his pediatric residency at the University of South Florida/Tampa General Hospital where he first began utilizing wholistic therapies. Dr. David has been in private practice since 1997 and in 2005 opened Wholistic Pediatrics & Family Care, his medical practice in Tampa, Florida. In 2010, Dr. David was appointed Assistant Professor at the University of South Florida College of Nursing. In 2016, he launched Wholistic ReLeaf to help qualified patients become certified to use medical cannabis.